Product Code: BMIRE00029043
The Asia Pacific clinic casting and splinting products market is expected to grow from US$ 284.43 million in 2022 to US$ 444.44 million by 2030. It is estimated to grow at a CAGR of 5.7% from 2022 to 2030.
Advancements in 3D Technology in Casting and Splinting Fuels Asia Pacific Clinic Casting and Splinting Products Market
The rapid development of 3D printing implies fast penetration 3D printing techniques into the healthcare system, especially for treating fractures. In rehabilitation tool manufacturing, 3D printing technology is applied to orthopedic cast fabrication to create patient-specific features with an appropriate fit and a ventilated structure. The novel casting technology heals the fracture effectively without casting complications. The 3D-printed cast is customized and lightweight.
Patient-specific and 3D-printed casts develop proper fit according to the shape of the injured arm. Thus, the risk of stress concentration can be reduced since large contact areas are created. 3D printing makes the fabrication process simpler and in shorter period, especially in a customized design. On that account, the application of 3D printing in biomedical engineering is growing and promising to be practiced in the future. Also, the customizable hand cast made by using 3D printing technique is reliable and provides comfort and satisfaction to the patients. 3D printing is an evolving technology that has a potential application in treating pediatric forearm fractures. These factors can lead to better patient compliance. The 3D-printed cast proved to be superior in terms of satisfaction, comfort, and perceived function as compared to the fiberglass. Thus, the above-mentioned factors would create significant opportunities for the Asia Pacific clinic casting and splinting products market in the coming years.
Asia Pacific Clinic Casting and Splinting Products Market Overview
The Asia Pacific clinic casting and splinting products market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Rising cases of fractures due to accidents in countries such as India, China, Indonesia, and Australia, increase in geriatric population who are susceptible to fractures and sprains, and increase in prevalence of musculoskeletal disorders. Distal radius fracture (DRF) is one of the most common fall-related fractures of the upper extremities. According to Bioscientifica Ltd, in China, the age-adjusted overall incidence of DRF varies between 100 and 300 per 100,000 person-years. As osteoporosis occurrence is high in the geriatric population, the incidence of DRF also increases in this population. According to the 2020 census, people aged above 65 years accounted for 13.5% of the total population of China. As per World Bank Group data, in 2022, ~14% of the total population of China is aged above 65 years. A rise in the geriatric population in China increases the incidence of DRF in this population. Splinters and casts are used to immobilize the distal radius for treatment. Hence, an increase in cases of DRF in China is fueling the growth of the Asia Pacific clinic casting and splinting products market in China.
Asia Pacific Clinic Casting and Splinting Products Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Clinic Casting and Splinting Products Market Segmentation
The Asia Pacific clinic casting and splinting products market is segmented into product, application, material, and country.
Based on product, the Asia Pacific clinic casting and splinting products market is segmented into casting and splinting. The casting segment held a larger share of the Asia Pacific clinic casting and splinting products market in 2022. The casting is sub-segmented into casts, tapes, cutters, and casting accessories. The splinting segment is further segmented into splints and splinting accessories.
Based on application, the Asia Pacific clinic casting and splinting products market is segmented into acute fractures or sprains, tendon and ligament injuries, and others. The acute fractures segment held the largest share of the Asia Pacific clinic casting and splinting products market in 2022.
Based on material, the Asia Pacific clinic casting and splinting products market is segmented into Plaster of Paris, fiberglass, and others. The Plaster of Paris segment held the largest share of the Asia Pacific clinic casting and splinting products market in 2022.
Based on country, the Asia Pacific clinic casting and splinting products market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific clinic casting and splinting products market in 2022.
3M Co, DeRoyal Industries Inc, Enovis Corp, Essity AB, Ossur hf, Performance Health Holding Inc, Prime Medical Inc, and Zimmer Biomet Holdings Inc are some of the leading companies operating in the Asia Pacific clinic casting and splinting products market.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific Clinic Casting and Splinting Products Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific Clinic Casting and Splinting Products Market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Asia Pacific Clinic Casting and Splinting Products Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 Asia Pacific PEST Analysis
5. Asia Pacific Clinic Casting and Splinting Products Market - Key Industry Dynamics
- 5.1 Market Drivers
- 5.1.1 Rising Prevalence of Musculoskeletal Conditions
- 5.1.2 High Prevalence of Age-Related Orthopedic Disorders
- 5.2 Key Market Restraints
- 5.2.1 Complications Related to Casting and Splinting
- 5.3 Key Market Opportunities
- 5.3.1 Advancements in 3D Technology in Casting and Splinting
- 5.4 Future Trends
- 5.4.1 Rising Adoption of Fiberglass Material for Casting and Splinting
- 5.5 Impact Analysis
6. Clinic Casting and Splinting Products Market - Asia Pacific Market Analysis
- 6.1 Asia Pacific Clinic Casting and Splinting Products Market Revenue (US$ Mn), 2022 - 2030
7. Asia Pacific Clinical Casting and Splinting Products Market - Revenue and Forecast to 2030 - by Product
- 7.1 Overview
- 7.2 Asia Pacific Clinical Casting and Splinting Products Market Revenue Share, by Product 2022 & 2030 (%)
- 7.3 Casting
- 7.3.1 Overview
- 7.3.2 Casting: Asia Pacific Clinical Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.2.1 Casts
- 7.3.2.1.1 Overview
- 7.3.2.1.2 Casts: Asia Pacific Clinical Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.2.2 Tapes
- 7.3.2.2.1 Overview
- 7.3.2.2.2 Tapes: Asia Pacific Clinical Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.2.3 Cutters
- 7.3.2.3.1 Overview
- 7.3.2.3.2 Cutters: Asia Pacific Clinical Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.2.4 Casting Accessories
- 7.3.2.4.1 Overview
- 7.3.2.4.2 Casting Accessories: Asia Pacific Clinical Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4 Splinting
- 7.4.1 Overview
- 7.4.2 Splinting: Asia Pacific Clinical Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.2.1 Splints
- 7.4.2.1.1 Overview
- 7.4.2.1.2 Splints: Asia Pacific Clinical Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.2.2 Splinting Accessories
- 7.4.2.2.1 Overview
- 7.4.2.2.2 Splinting Accessories: Asia Pacific Clinical Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Clinical Casting and Splinting Products Market - Revenue and Forecast to 2030 - by Application
- 8.1 Overview
- 8.2 Asia Pacific Clinical Casting and Splinting Products Market Revenue Share, by Application 2022 & 2030 (%)
- 8.3 Acute Fracture or Sprains
- 8.3.1 Overview
- 8.3.2 Acute Fracture or Sprains: Asia Pacific Clinical Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4 Tendon and Ligament Injuries
- 8.4.1 Overview
- 8.4.2 Tendon and Ligament Injuries: Asia Pacific Clinical Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
- 8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Asia Pacific Clinical Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Clinical Casting and Splinting Products Market - Revenue and Forecast to 2030 - by Material
- 9.1 Overview
- 9.2 Asia Pacific Clinical Casting and Splinting Products Market Revenue Share, by Material 2022 & 2030 (%)
- 9.3 Plaster of Paris
- 9.3.1 Overview
- 9.3.2 Plaster of Paris: Asia Pacific Clinical Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
- 9.4 Fiberglass
- 9.4.1 Overview
- 9.4.2 Fiberglass: Asia Pacific Clinical Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
- 9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: Asia Pacific Clinical Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 - Country Analysis
- 10.1 Asia Pacific Clinic Casting and Splinting Products Market
- 10.1.1 Overview
- 10.1.1.1 China: Asia Pacific Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.2 China: Asia Pacific Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.2.1 China: Asia Pacific Clinic Casting and Splinting Products Market, by Product, 2020-2030 (US$ Million)
- 10.1.1.2.1.1 China: Asia Pacific Clinic Casting and Splinting Products Market, for Casting by Product, 2020-2030 (US$ Million)
- 10.1.1.2.1.2 China: Asia Pacific Clinic Casting and Splinting Products Market, for Splinting by Product, 2020-2030 (US$ Million)
- 10.1.1.2.2 China: Asia Pacific Clinic Casting and Splinting Products Market, By Application, 2020-2030 (US$ Million)
- 10.1.1.2.3 China: Asia Pacific Clinic Casting and Splinting Products Market, By Material, 2020-2030 (US$ Million)
- 10.1.1.3 Japan: Asia Pacific Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.4 Japan: Asia Pacific Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.4.1 Japan: Asia Pacific Clinic Casting and Splinting Products Market, by Product, 2020-2030 (US$ Million)
- 10.1.1.4.1.1 Japan: Asia Pacific Clinic Casting and Splinting Products Market, for Casting by Product, 2020-2030 (US$ Million)
- 10.1.1.4.1.2 Japan: Asia Pacific Clinic Casting and Splinting Products Market, for Splinting by Product, 2020-2030 (US$ Million)
- 10.1.1.4.2 Japan: Asia Pacific Clinic Casting and Splinting Products Market, By Application, 2020-2030 (US$ Million)
- 10.1.1.4.3 Japan: Asia Pacific Clinic Casting and Splinting Products Market, By Material, 2020-2030 (US$ Million)
- 10.1.1.5 India: Asia Pacific Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.6 India: Asia Pacific Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.6.1 India: Asia Pacific Clinic Casting and Splinting Products Market, by Product, 2020-2030 (US$ Million)
- 10.1.1.6.1.1 India: Asia Pacific Clinic Casting and Splinting Products Market, for Casting by Product, 2020-2030 (US$ Million)
- 10.1.1.6.1.2 India: Asia Pacific Clinic Casting and Splinting Products Market, for Splinting by Product, 2020-2030 (US$ Million)
- 10.1.1.6.2 India: Asia Pacific Clinic Casting and Splinting Products Market, By Application, 2020-2030 (US$ Million)
- 10.1.1.6.3 India: Asia Pacific Clinic Casting and Splinting Products Market, By Material, 2020-2030 (US$ Million)
- 10.1.1.7 Australia: Asia Pacific Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.8 Australia: Asia Pacific Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.8.1 Australia: Asia Pacific Clinic Casting and Splinting Products Market, by Product, 2020-2030 (US$ Million)
- 10.1.1.8.1.1 Australia: Asia Pacific Clinic Casting and Splinting Products Market, for Casting by Product, 2020-2030 (US$ Million)
- 10.1.1.8.1.2 Australia: Asia Pacific Clinic Casting and Splinting Products Market, for Splinting by Product, 2020-2030 (US$ Million)
- 10.1.1.8.2 Australia: Asia Pacific Clinic Casting and Splinting Products Market, By Application, 2020-2030 (US$ Million)
- 10.1.1.8.3 Australia: Asia Pacific Clinic Casting and Splinting Products Market, By Material, 2020-2030 (US$ Million)
- 10.1.1.9 South Korea: Asia Pacific Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.10 South Korea: Asia Pacific Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.10.1 South Korea: Asia Pacific Clinic Casting and Splinting Products Market, by Product, 2020-2030 (US$ Million)
- 10.1.1.10.1.1 South Korea: Asia Pacific Clinic Casting and Splinting Products Market, for Casting by Product, 2020-2030 (US$ Million)
- 10.1.1.10.1.2 South Korea: Asia Pacific Clinic Casting and Splinting Products Market, for Splinting by Product, 2020-2030 (US$ Million)
- 10.1.1.10.2 South Korea: Asia Pacific Clinic Casting and Splinting Products Market, By Application, 2020-2030 (US$ Million)
- 10.1.1.10.3 South Korea: Asia Pacific Clinic Casting and Splinting Products Market, By Material, 2020-2030 (US$ Million)
- 10.1.1.11 Rest of Asia Pacific: Asia Pacific Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.12 Rest of Asia Pacific: Asia Pacific Clinic Casting and Splinting Products Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.12.1 Rest of Asia Pacific: Asia Pacific Clinic Casting and Splinting Products Market, by Product, 2020-2030 (US$ Million)
- 10.1.1.12.1.1 Rest of Asia Pacific: Asia Pacific Clinic Casting and Splinting Products Market, for Casting by Product, 2020-2030 (US$ Million)
- 10.1.1.12.1.2 Rest of Asia Pacific: Asia Pacific Clinic Casting and Splinting Products Market, for Splinting by Product, 2020-2030 (US$ Million)
- 10.1.1.12.2 Rest of Asia Pacific: Asia Pacific Clinic Casting and Splinting Products Market, By Application, 2020-2030 (US$ Million)
- 10.1.1.12.3 Rest of Asia Pacific: Asia Pacific Clinic Casting and Splinting Products Market, By Material, 2020-2030 (US$ Million)
11. Asia Pacific Clinic Casting and Splinting Products Market-Industry Landscape
- 11.1 Overview
- 11.2 Recent Growth Strategies
12. Company Profiles
- 12.1 DeRoyal Industries Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Prime Medical Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 3M Co
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Essity AB
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Zimmer Biomet Holdings Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Ossur hf
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Performance Health Holding Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 Enovis Corp
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
13. Appendix
- 13.1 About Us
- 13.2 Glossary of Terms